Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

CHMP3 Activators

CHMP3, also known as Charged Multivesicular Body Protein 3, is a component of the endosomal sorting complex required for transport-III (ESCRT-III). CHMP3 activators encompass a range of chemical compounds that indirectly facilitate the functional activity of CHMP3 through various intracellular signaling pathways and membrane trafficking processes. These activators are not direct agonists in the classical sense but exert their influence on the pathways that CHMP3 is inherently a part of, often leading to the enhanced assembly and disassembly dynamics of the ESCRT-III complex. For instance, certain phospholipids and their analogs can modulate the membrane curvature and lipid composition, which is crucial for the membrane scission events that CHMP3 is involved in. These compounds, by altering the lipid environment, can enhance the propensity for CHMP3 to participate in the formation of multivesicular bodies (MVBs), thus indirectly supporting its role in membrane trafficking.

Moreover, small molecules that influence the ATPase activity of VPS4, which is essential for disassembling the ESCRT-III complex, indirectly impact CHMP3's function. By modulating the availability or efficiency of VPS4, these activators can indirectly enhance CHMP3's role in ESCRT-III mediated processes, such as the final stages of cytokinesis and the budding of certain enveloped viruses. Additionally, compounds that alter the ionic environment within the cell can affect the electrostatic interactions necessary for CHMP3 polymerization and stability, thereby facilitating its assembly into functional complexes. Collectively, CHMP3 activators work through these nuanced mechanistic pathways to support the protein's essential role in cellular homeostasis, specifically in the trafficking of vesicles and the sorting of ubiquitinated proteins destined for degradation in the lysosome.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Bafilomycin A1 specifically inhibits V-ATPase, leading to the disruption of endosomal acidification. This inhibitor can indirectly enhance the function of CHMP3 by affecting the endosomal sorting complex and potentially promoting alternative pathways of vesicle trafficking.